BCBS Kansas Medical Policy Updates – January 2019

Click here to view the Blue Cross Blue Shield Kansas Medical Policy Updates »

January 2019 BCBS Kansas Medical Policy Updates:

• Ambulatory Event Monitors and Mobile Cardiac Outpatient Telemetry
• Amniotic Membrane and Amniotic Fluid
• Androgens and Anabolic Steroids
• Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis in Patients with Breast Cancer
• Axial Lumbosacral Interbody Fusion
• Bio-Engineered Skin and Soft Tissue Substitutes
• BRCA1  and BRCA2  Testing
• Cardiac Hemodynamic Monitoring for the Management of Heart Failure in the Outpatient Setting
• Corneal Collagen Cross-Linking
• Deep Brain Stimulation
• Digital Breast Tomosynthesis
• Drug Testing in Pain Management and Substance Use Disorder Treatment
• Emflaza (deflazacort)
• Expanded Molecular Panel Testing of Cancers to Identify Targeted Therapies
• Gene Expression Profiling for Uveal Melanoma
• H.P. Acthar Gel  (repository corticotropin)
• Hepatitis C Second Generation Antivirals
• Intra-Articular Hyaluronan Injections for Osteoarth
• Lucemyra (lofexidine)
• Magnetic Resonance Imaging (MRI) of the Breast
• Microwave Tumor Ablation
• Miscellaneous Genetic and Molecular Diagnostic Tests
• Molecular Markers in Fine Needle Aspirates of the Thyroid
• Natpara (parathyroid hormone)
• Noninvasive Techniques for the Evaluation and Monitoring of Patients with Chronic Liver Disease
• Novel Biomarkers in Risk Assessment and Management of CVD
• Opioid Immediate Release
• Opioids, Extended Release (ER)
• Oral Anticoagulants
• Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory Disorders
• Photodynamic Therapy for Choroidal Neovascularization
• Sacral Nerve Neuromodulation / Stimulation
• Self Administered Oncology Agents
• Sensorimotor and Neurobehavioral Status Exams
• Soliris® (eculizumab)
• Strensiq (asfotase alfa)
• Subtalar Arthroereisis
• Topical Doxepin
• Total Artificial Hearts and Ventricular Assist Devices
• Urea Cycle Disorders
• Vagus Nerve Stimulation
• Varicose Veins
• Xolair (omalizumab)

Click here to view the Blue Cross Blue Shield Kansas Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.